Nachrichten zur Vertex Pharmaceuticals Inc. Aktie

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Oppenheimer: Oppenheimer hebt in einer aktuellen Aktienanalyse das Kursziel für die Aktie von Vertex…

Vertex Pharmaceuticals: Gute Logik - Aktienanalyse

Charlotte, NC (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Truist: Joon Lee, Analyst von Truist, stuft in einer aktuellen Aktienanalyse die Aktie von…

Vertex Pharmaceuticals: Abstufung wegen Bewertung, neues Kursziel - Aktienanalyse

London (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Barclays: Barclays stuft in einer aktuellen Aktienanalyse die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…

Vertex Pharmaceuticals: Kursziel um 100 USD angepasst

New York (www.aktiencheck.de) - Rating-Update: Andrew Fein, Analyst von H.C. Wainwright & Co, empfiehlt die Aktie von Vertex Pharmaceuticals Inc. (ISIN:…

Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript

VRTX earnings call for the period ending June 30, 2024.…

Vertex Pharmaceuticals: Kursziel angehoben

Vancouver (www.aktiencheck.de) - Rating-Update: Die Analysten von Canaccord Genuity bewerten die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807, Ticker-Symbol:…

Vertex Pharmaceuticals: Kursziel vor Q2-Zahlen angehoben - Aktienanalyse

San Francisco (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Citizens JMP Securities: Die Analysten von Citizens JMP Securities heben in einer aktuellen Aktienanalyse…

Is Vertex Pharmaceuticals Monopoly in Danger?

As a shareholder, I am nowhere close to panic mode.…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow

Vertex shares have soared by triple-digit percentages over the past three years.…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow @themotleyfool #stocks $VRTX

Vertex shares have soared by triple-digit percentages over the past three years.…

Vertex Pharmaceuticals: Günstiges Chance/Risiko-Verhältnis - Aktienanalyse

Milwaukee (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Robert W. Baird: Die Analysten von Robert W. Baird nehmen die Coverage der Aktie von…

Vertex Pharmaceuticals: Alpine-Übernahme im Fokus - Kursziel auf 500 USD erhöht - Aktienanalyse

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von H.C. Wainwright & Co.: Die Analysten von H.C. Wainwright & Co. stufen die Aktie…

Vertex Pharmaceuticals EVP and CMO sells $1.1M in stock By Investing.com

Vertex Pharmaceuticals EVP and CMO sells $1.1M in stock…

Did Vertex Pharmaceuticals Just Invent the Next Ozempic?

Vertex Pharmaceuticals likely has a breakthrough medicine on its hands.…

Vertex Pharmaceuticals: Coverage aufgenommen

London (www.aktiencheck.de) - Rating-Update: Die Analysten von Redburn Atlantic nehmen die Coverage der Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…

Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors

BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to…

Vertex Pharmaceuticals: Neues Kursziel

San Francisco (www.aktiencheck.de) - Rating-Update: Die Analysten von Wells Fargo Advisors stufen die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…

Vertex Pharmaceuticals: Fortschritte in der Pipeline, M&A-Aktivitäten und finanzielle Stärke im Fokus - Aktienanalyse

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Argus Research: Jasper Hellweg, Analyst von Argus Research, erhöht in einer aktuellen Aktienanalyse sein…

Analyst Report: Vertex Pharmaceuticals, Inc.

…

Cystic Fibrosis Therapeutics Global Strategic Business Report 2023-2030 Featuring Key Players - AbbVie, Galapagos, Genentech, Gilead Sciences, Novartis, and Vertex Pharmaceuticals

Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Therapeutics - Global Strategic Business Report" report has…

Vertex Pharmaceuticals: Kursziel gekappt

Toronto (www.aktiencheck.de) - Rating-Update: Die Analysten vom Investmenthaus RBC Capital Markets bestätigen das "sector-perform"-Rating für die Aktie von Vertex Pharmaceuticals Inc.…

Vertex Pharmaceuticals: VX-548 im Fokus - Aktienanalyse

Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von BMO Capital Markets: Die Analysten von BMO Capital Markets stufen die Aktie von Vertex Pharmaceuticals…

Is It Too Late to Buy Vertex Pharmaceuticals Stock?

Shares of the growing biotech company have doubled in three years.…

Is It Too Late to Buy Vertex Pharmaceuticals Stock? @themotleyfool #stocks $VRTX

Shares of the growing biotech company have doubled in three years.…

3 High-Flying Stocks That Could Soar Even More

The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.…

ADDvise receives order worth USD 1.4 million

Axelerist, an ADDvise Group company, has received an order from Vertex Pharmaceuticals, a global biotechnology company, for the sale and…

Vertex Pharmaceuticals executive sells shares worth over $13k By Investing.com

Vertex Pharmaceuticals executive sells shares worth over $13k…

Vertex Is Writing A New Playbook For Pharma R&D. And It’s Working.

Vertex Pharmaceuticals (NDAQ: VRTX) path to becoming a top 20 pharma company with over a $100 billion market cap has…

Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy

The biotechs shares dropped following its latest quarterly update, but that shouldnt matter to long-term investors.…

Vertex Pharmaceuticals: Höheres Kursziel

Boston, MA (www.aktiencheck.de) - Rating-Update: Die Analysten von Leerink Partners wiederholen ihre Empfehlung "outperform" für die Aktie von Vertex Pharmaceuticals Inc.…

Vertex Pharmaceuticals: Kursziel hochgesetzt

Toronto (www.aktiencheck.de) - Rating-Update: Im Rahmen seiner Einschätzung bleibt Brian Abrahams, Analyst vom Investmenthaus RBC Capital Markets, bei seiner "sector-perform"-Bewertung für…

Vertex Pharmaceuticals: Kurszielanhebung

Minneapolis (www.aktiencheck.de) - Rating-Update: Die Analysten von Piper Sandler bewerten die Aktie des US-Biotechkonzerns Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807,…

5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip @themotleyfool #stocks $VRTX

New drugs in development and a lack of significant patent cliffs ahead make this a great pharma stock to buy…

5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip

New drugs in development and a lack of significant patent cliffs ahead make this a great pharma stock to buy…

Futures Mixed As Disney Dives On Revenue Miss

Key earnings movers include Datadog, Palantir and Vertex Pharmaceuticals.…

Vertex Pharmaceuticals, Inc. (VRTX) Q1 2024 Earnings Call Transcript

…

Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript

VRTX earnings call for the period ending March 31, 2024.…

Vertex Stock Flat On Reiterated Outlook Despite First-Quarter Beat

Vertex Pharmaceuticals beat first-quarter sales and earnings forecasts, but shares were little moved on the reiterated guidance.…

The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals

Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.…

Vertex Pharmaceuticals: Kurszielsenkung

Charlotte (www.aktiencheck.de) - Rating-Update: Die Analysten von BofA Securities bewerten die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807, Ticker-Symbol:…

Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy? @themotleyfool #stocks $VRTX $CRSP $ALPN

Vertex is broadening its portfolio.…

Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?

Vertex is broadening its portfolio.…

dpa-AFX ProFeed